139 related articles for article (PubMed ID: 8777377)
1. Alterations of p53 and expression of WAF1/p21 in human thyroid tumors.
Zedenius J; Larsson C; Wallin G; Bäckdahl M; Aspenblad U; Höög A; Børresen AL; Auer G
Thyroid; 1996 Feb; 6(1):1-9. PubMed ID: 8777377
[TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
3. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y; Zou M; Farid NR; al-Sedairy ST
Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
[TBL] [Abstract][Full Text] [Related]
4. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
5. p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation.
Marchetti A; Doglioni C; Barbareschi M; Buttitta F; Pellegrini S; Bertacca G; Chella A; Merlo G; Angeletti CA; Dalla Palma P; Bevilacqua G
Oncogene; 1996 Mar; 12(6):1319-24. PubMed ID: 8649834
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines.
Jossart GH; Epstein HD; Shaver JK; Weier HU; Greulich KM; Tezelman S; Grossman RF; Siperstein AE; Duh QY; Clark OH
J Clin Endocrinol Metab; 1996 Oct; 81(10):3498-504. PubMed ID: 8855792
[TBL] [Abstract][Full Text] [Related]
7. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
Moretti F; Farsetti A; Soddu S; Misiti S; Crescenzi M; Filetti S; Andreoli M; Sacchi A; Pontecorvi A
Oncogene; 1997 Feb; 14(6):729-40. PubMed ID: 9038381
[TBL] [Abstract][Full Text] [Related]
8. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
Kralj M; Husnjak K; Körbler T; Pavelić J
Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
[TBL] [Abstract][Full Text] [Related]
9. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
10. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis.
Pasz-Walczak G; Kordek R; Faflik M
Pathol Res Pract; 2001; 197(10):683-9. PubMed ID: 11700890
[TBL] [Abstract][Full Text] [Related]
11. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer.
Ahrendt SA; Brown HM; Komorowski RA; Zhu YR; Wilson SD; Erickson BA; Ritch PS; Pitt HA; Demeure MJ
Surgery; 2000 Oct; 128(4):520-30. PubMed ID: 11015084
[TBL] [Abstract][Full Text] [Related]
12. Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.
Ito Y; Kobayashi T; Takeda T; Komoike Y; Wakasugi E; Tamaki Y; Tsujimoto M; Matsuura N; Monden M
Br J Cancer; 1996 Oct; 74(8):1269-74. PubMed ID: 8883416
[TBL] [Abstract][Full Text] [Related]
13. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
14. p53 and p21(WAF1) expression in lymphocytic thyroiditis and thyroid tumors.
Okayasu I; Osakabe T; Onozawa M; Mikami T; Fujiwara M
Clin Immunol Immunopathol; 1998 Aug; 88(2):183-91. PubMed ID: 9714696
[TBL] [Abstract][Full Text] [Related]
15. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
[TBL] [Abstract][Full Text] [Related]
16. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
17. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.
Lam KY; Lo CY; Chan KW; Wan KY
Ann Surg; 2000 Mar; 231(3):329-38. PubMed ID: 10714625
[TBL] [Abstract][Full Text] [Related]
18. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer.
Pasz-Walczak G; Kordek R
Pol J Pathol; 2000; 51(2):63-9. PubMed ID: 10974928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
